Pulmatrix (PULM) Cash from Operations (2013 - 2026)
Pulmatrix (PULM) posted Cash from Operations of 1067000.0 for Q1 2026, down 51.13% sequentially from 706000.0 in Q4 2025, and up 41.15% YoY from 755948.03 in Q1 2025.
Pulmatrix (PULM) Cash from Operations (2013 - 2026) Analysis & Trends
Pulmatrix has reported Cash from Operations for 14 years, with the latest figure at 1067000.0 in Q1 2026.
- Quarterly Cash from Operations rose 41.15% year-over-year to 1067000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4687000.0 (up 52.22% YoY) and the FY2025 annual result came in at 5433000.0, up 49.3% from the prior year.
- Cash from Operations fell to 1067000.0 in Q1 2026 per PULM's latest filing, from 706000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 706000.0 in Q4 2025 and troughed at 6144000.0 in Q1 2022.
- A 5-year average of 3091588.24 and a median of 3059000.0 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations slipped 14.93% in 2023, then surged 66.3% in 2025.
- Over 5 years, Cash from Operations stood at 5046000.0 in 2022, then surged by 60.15% to 2011000.0 in 2023, then jumped by 37.29% to 1261000.0 in 2024, then soared by 44.01% to 706000.0 in 2025, then sank by 51.13% to 1067000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 1067000.0, 706000.0, and 1031000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | -1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11 Mn |
| Jun 30, 2026 | -1.11 Mn |
| Mar 31, 2026 | -1.07 Mn |
| Mar 31, 2026 | -1.07 Mn |
| Dec 31, 2025 | -706,000.00 |
| Dec 31, 2025 | -706,000.00 |
| Sep 30, 2025 | -1.03 Mn |
| Sep 30, 2025 | -1.03 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Mar 31, 2025 | -1.81 Mn |
| Mar 31, 2025 | -1.81 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | -3.06 Mn |
| Sep 30, 2024 | -3.06 Mn |
| Jun 30, 2024 | -3.68 Mn |
| Jun 30, 2024 | -3.68 Mn |
| Mar 31, 2024 | -2.72 Mn |
| Mar 31, 2024 | -2.72 Mn |